西藏心肺触诊听诊电脑模拟器（学生实验机）(海南未组装的半侧人体骨骼模型) (今日更新中)

President Donald Trump's ex-wife Ivana doesn't think he should run for reelection in 2020. In an interview with Page Six, Ivana Trump said her ex-husband should instead enjoy his fortunes. “I’ll tell you something, I don’t think it’s necessary,” she told Page Six. “He has a good life and he has everything. Donald is going to be 74, 73 for the next [election] and maybe he should just go and play golf and enjoy his fortune."Ivana Trump was married to Donald from 1977 to 1992. The couple had three children: Eric, Donald Jr. and Ivanka. Despite being divorced for 26 years, Ivana remains in close contact with the President, saying they talk at least once a month. Ivana Trump believes her ex-husband probably misses some of the freedoms he had before entering the White House. "I don’t think he probably knew how much is involved of being the President," she told Page Six. "It’s so [much] information — you have to know the whole world.”Ivana Trump added during the interview that she feels for Trump's current wife Melania as speculation swirls around Trump's sex life, and his alleged relationship with porn star Stormy Daniels. "I feel bad for [Melania] because I know how bad I did feel. It hurts a lot,” she told Page Six.During their 15-year marriage, Ivana said she never suspected Donald of cheating on her. “Donald was always in the office and coming home, so I had no idea how he had the time to cheat,” she told Page Six. To see the full interview, click here.  1564

RANDALLSTOWN, Md. — The current wave of COVID-19 continues to put a strain on doctors and nurses.There are concerns that the rapidly increasing number of hospitalizations and patient deaths is putting the mental health of health care workers at risk.After dealing with the coronavirus for nine months, with doctors and nurses already stretched thin, they brace themselves for what another wave of COVID-19 will bring.An intensive care unit nurse at Northwest Hospital in Randallstown, Maryland, said “at the height of this pandemic, we were essentially in survival mode, going to work everyday with this new virus, being fearful. Fearful that we're going to take this home to our families, not really knowing enough about it to know are we really protected with what we're doing.”The ICU nurse admits the ongoing pandemic doesn't just have frontline workers concerned about their physical health, now there's also a concern for the state of their mental health.“The patients are sicker, than our traditional, regular ICU patients that come in, which in itself has taken a toll because we are exhausting all medical intervention possible and as a nurse, putting your heart and soul into taking care of and trying to save a patient and we fail,” the nurse said.COVID safety protocols leave patients to die alone, without anyone by their side except for a nurse.“You know, I’m going into a room, to hold a hand, or to hold an iPad and let a family say goodbye. That probably has been the toughest part for me. As an ICU nurse, I’m used to that. I’m used to hearing from patients and families at end of life but not to this capacity that we're seeing with the virus. Not these numbers of patients. And also not being the only contact that they're getting,” the nurse said.A recent survey by the non-profit organization Mental Health America, found the pandemic is taking a toll on the mental health of doctors and nurses.Mental Health America president and CEO Paul Gionfriddo said “the majority of them are experiencing conditions like stress and anxiety but more than half are questioning whether or not they're in the wrong profession at this point. Three-quarters are concerned about their kids and whether or not they're going to physically, negatively affect their kids or even emotionally whether or not they're giving the support to their children and families that they need.”Gionfriddo worries about the long-term effects the pandemic will have on frontline workers.“Some people will develop PTSD, others will develop psychosis, others will develop depression. The whole range of mental health conditions will emerge out of this pandemic among people who were healthy going into it, and who would have remained healthy if they were not put under the stress and pressure that they've experienced in trying to provide care to others during the pandemic,” Gionfriddo said.Considering the increasing level of stress from dealing with life and death on a day-to-day basis, some may wonder what keeps this ICU nurse going to work everyday instead of calling out or just calling it quits.“I took an oath as a nurse, and I think that's instilled in a lot of us. We have that responsibility, to the community and our families,” the nurse said.She decided to become a nurse and she said it's in her family. Her stepmother is a nurse, one of her aunts is a nurse, and it's something she always wanted to do, which is help people.This story originally reported by Mark Roper on WMAR2News.com. 3495

Rescuers worked through the night to attempt to account for all of the victims of Tuesday's Morandi Bridge disaster in Genoa, as Italy's President called for a "serious and severe examination" into why the bridge suddenly collapsed.At least 36 people died when a major section of the motorway in Italy's northwest partially collapsed during a heavy storm, according to Chief of Police Col. Riccardo Sciuto. One entire family died in the accident, Sciuto added.Three French nationals are among the dead, according to a statement released by the French Foreign Affairs Ministry on Wednesday.The death toll is likely to rise as multiple people remain missing. 664

Researchers published what they say is the first case of a living person diagnosed with the degenerative brain disease chronic traumatic encephalopathy or CTE.While unnamed in the study, lead author Dr. Bennet Omalu confirmed to CNN that the subject of the case was former NFL player Fred McNeill -- who died in 2015.Omalu is credited with first discovering CTE in professional football players. Until now, the only way to diagnose the disease is with a brain exam after death.The diagnosis was first made using an experimental brain scan that can trace a signature protein of CTE called tau. The authors then confirmed the diagnosis with an autopsy. The case study was published in the journal Neurosurgery this week.'It looked like just depression'Omalu first presented these findings exclusively to CNN's chief medical correspondent, Dr. Sanjay Gupta, in 2016. McNeill's wife, Tia, and his two sons, Gavin and Fred Jr., told Gupta then that they saw Fred transform from a fun loving family man at the center of their lives into a man who was dealing with symptoms of memory loss, anger and depression that tore their family apart."There are some times where the father is the stronghold in the family, or the anchor. If you lose that, everything kind of falls apart. That's kind of what happened for us. It looked like financial issues at first; it looked like marital issues, and they separated; then it looked like just depression," Gavin told Gupta.CTE is known for plaguing people with Alzheimer's like symptoms such as memory loss, rage, mood swings, and in some cases, suicidal ideation.Severity of the disease is categorized into four stages, with stage 4 being the most severe. While researchers don't know exactly why certain people develop the disease and others don't, they believe that it results from repeated blows to the head that trigger a build up of tau proteins in the brain.CTE has been called football's "concussion crisis," however experts point out that CTE can develop from any repeated head injury. According to the Boston University CTE Center, "this trauma includes both concussions that cause symptoms and subconcussive hits to the head that cause no symptoms." These subconcussive hits can include the repeated trauma the brain experiences from constant plays, hitting the turf, and tackling. Wrestlers, boxers, and military troops have also been diagnosed with the disease.Seeing CTEWhile McNeill is the first case to be confirmed with an autopsy, the experimental technology has been used on at least a dozen other former NFL players, including Pro Football Hall of Famer, Dallas Cowboy Tony Dorsett. Omalu helped develop and is invested in the diagnostic exam, which uses a radioactive "tracer" called FDDNP to bind to tau proteins in the brain. The tau proteins can then be seen on a PET scan of the brain.Critics have said the protein also can highlight another protein called amyloid, which may be indicative of Alzheimer's or other forms of dementia. But Omalu noted that in CTE, tau makes distinctive patterns in the brain. It has a "specific topographic signature," he said, and that pattern can be detected in imaging.Omalu said he and his team are currently raising money to start a phase 3 clinical trial to further test the technology and replicate what they have seen in McNeill. He anticipates that once funds are raised, it will take another two to three years for the trial and then another year, at least, for approval from the US Food and Drug Administration. When asked, how soon a commercial test could be available, Omalu predicted it could be as soon as a few years. "We are looking at less than five years," he said.  3711

President Donald Trump’s physical Dr. Sean Conley confirmed Friday that the president is taking an experimental antibody treatment to help him fight the coronavirus following his diagnosis this morning.Dr. Conley said Friday afternoon that Trump is "fatigued."Trump is taking the Regeneron antibody cocktail, which is currently in a clinical trial. Conley said that Trump has been treated with a single 8 gram dose, which Conley said was infused "without incident."Trump is also said to be taking Vitamin D, zinc, famotidine, melatonin and daily aspirin. The Regeneron trial has only been tried on 275 patients as of this week, but the company said earlier this week that it has showed promising results.Regeneron confirmed that Trump was given the treatment under a "compassionate use request.""In the USA, this type of compassionate use program is also known as an Expanded Access Program (EAP) and is intended for patients with serious or life-threatening conditions, who do not have any viable or available treatment options, and are unable to participate in ongoing clinical trials," Regeneron said in a statement. The plan is to enroll 2,000 patients in early studies of the treatment."After months of incredibly hard work by our talented team, we are extremely gratified to see that Regeneron's antibody cocktail REGN-COV2 rapidly reduced viral load and associated symptoms in infected COVID-19 patients," said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer of Regeneron. "The greatest treatment benefit was in patients who had not mounted their own effective immune response, suggesting that REGN-COV2 could provide a therapeutic substitute for the naturally-occurring immune response. These patients were less likely to clear the virus on their own, and were at greater risk for prolonged symptoms.The treatment is a combination of two monoclonal and was designed specifically to block infectivity of SARS-CoV-2, the virus that causes COVID-19, the company said.“The two potent, virus-neutralizing antibodies that form REGN-COV2 bind non-competitively to the critical receptor binding domain of the virus's spike protein, which diminishes the ability of mutant viruses to escape treatment and protects against spike variants that have arisen in the human population, as detailed in Science.” Regeneron said in a statement. “Preclinical studies have shown that REGN-COV2 reduced the amount of virus and associated damage in the lungs of non-human primates.”According to Regeneron, the treatment has been tried on hospitalized and non-hospitalized patients and as a preventative for those who have had close contact with coronavirus patients. So far, the drug has been particularly promising for non-hospitalized patients.Regeneron said the treatment reduces the viral load from the coronavirus, and boosts the body’s immune response to the virus. 2890

来源：资阳报